ATE395325T1 - Neues kristallines stilben-derivat und verfahren zu dessen herstellung - Google Patents
Neues kristallines stilben-derivat und verfahren zu dessen herstellungInfo
- Publication number
- ATE395325T1 ATE395325T1 AT01912367T AT01912367T ATE395325T1 AT E395325 T1 ATE395325 T1 AT E395325T1 AT 01912367 T AT01912367 T AT 01912367T AT 01912367 T AT01912367 T AT 01912367T AT E395325 T1 ATE395325 T1 AT E395325T1
- Authority
- AT
- Austria
- Prior art keywords
- crystal
- production
- new crystalline
- type
- water
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- PJANXHGTPQOBST-VAWYXSNFSA-N trans-stilbene Chemical class C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 title 1
- 239000013078 crystal Substances 0.000 abstract 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 3
- 230000003327 cancerostatic effect Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000002425 crystallisation Methods 0.000 abstract 1
- 230000008025 crystallization Effects 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 229940126601 medicinal product Drugs 0.000 abstract 1
- 238000000634 powder X-ray diffraction Methods 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 238000001179 sorption measurement Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/22—Separation; Purification; Stabilisation; Use of additives
- C07C231/24—Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/08—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000076887 | 2000-03-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE395325T1 true ATE395325T1 (de) | 2008-05-15 |
Family
ID=18594552
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01912367T ATE395325T1 (de) | 2000-03-17 | 2001-03-14 | Neues kristallines stilben-derivat und verfahren zu dessen herstellung |
Country Status (13)
Country | Link |
---|---|
US (1) | US6784315B2 (de) |
EP (1) | EP1264821B1 (de) |
JP (1) | JP4826051B2 (de) |
CN (1) | CN1221527C (de) |
AT (1) | ATE395325T1 (de) |
AU (1) | AU2001241140A1 (de) |
DE (1) | DE60133995D1 (de) |
DK (1) | DK1264821T3 (de) |
ES (1) | ES2306705T3 (de) |
PT (1) | PT1264821E (de) |
SI (1) | SI1264821T1 (de) |
TW (1) | TWI291459B (de) |
WO (1) | WO2001068587A1 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007254292A (ja) * | 2006-03-20 | 2007-10-04 | Nippon Polyurethane Ind Co Ltd | ジフェニルスルホンジイソシアネートの製造方法 |
FR2953518B1 (fr) | 2009-12-03 | 2012-01-20 | Sanofi Aventis | Procede de preparation d'un derive de combretastatine |
WO2013084150A1 (en) * | 2011-12-06 | 2013-06-13 | Sanofi | Novel crystal form of (2s)-2-amino-3-hydroxy-n-[2-methoxy-2-[(1z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl]propanamide and method of preparation thereof |
EP3184095A1 (de) | 2013-05-23 | 2017-06-28 | IP Gesellschaft für Management mbH | Verabreichungseinheiten die ein polymorph 1 von 2-(2-methylamino-pyrimidin-4-yl]-1h-indole-5-carboxylic acid [(s)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino)-ethyl]-amide beinhalten |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW334418B (en) * | 1995-03-07 | 1998-06-21 | Ajinomoto Kk | Stilbene derivatives and pharmaceutical compositions |
-
2001
- 2001-03-14 AT AT01912367T patent/ATE395325T1/de active
- 2001-03-14 EP EP01912367A patent/EP1264821B1/de not_active Expired - Lifetime
- 2001-03-14 WO PCT/JP2001/002028 patent/WO2001068587A1/ja active IP Right Grant
- 2001-03-14 SI SI200130846T patent/SI1264821T1/sl unknown
- 2001-03-14 DE DE60133995T patent/DE60133995D1/de not_active Expired - Lifetime
- 2001-03-14 PT PT01912367T patent/PT1264821E/pt unknown
- 2001-03-14 CN CNB018067336A patent/CN1221527C/zh not_active Expired - Fee Related
- 2001-03-14 DK DK01912367T patent/DK1264821T3/da active
- 2001-03-14 AU AU2001241140A patent/AU2001241140A1/en not_active Abandoned
- 2001-03-14 JP JP2001567685A patent/JP4826051B2/ja not_active Expired - Fee Related
- 2001-03-14 ES ES01912367T patent/ES2306705T3/es not_active Expired - Lifetime
- 2001-03-16 TW TW090106261A patent/TWI291459B/zh not_active IP Right Cessation
-
2002
- 2002-09-16 US US10/243,649 patent/US6784315B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DK1264821T3 (da) | 2008-09-08 |
DE60133995D1 (de) | 2008-06-26 |
TWI291459B (en) | 2007-12-21 |
SI1264821T1 (sl) | 2008-10-31 |
US20030065035A1 (en) | 2003-04-03 |
EP1264821B1 (de) | 2008-05-14 |
CN1418186A (zh) | 2003-05-14 |
EP1264821A1 (de) | 2002-12-11 |
PT1264821E (pt) | 2008-08-12 |
ES2306705T3 (es) | 2008-11-16 |
CN1221527C (zh) | 2005-10-05 |
AU2001241140A1 (en) | 2001-09-24 |
US6784315B2 (en) | 2004-08-31 |
EP1264821A4 (de) | 2005-06-08 |
WO2001068587A1 (fr) | 2001-09-20 |
JP4826051B2 (ja) | 2011-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU8794291A (en) | New oxazolopyridine derivatives, processes for preparing these and pharmaceutical compositions containing them | |
WO2000061568A8 (de) | Mit zuckerresten substituierte 1,4-benzothiazepin-1,1-dioxidderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung | |
HUP0401982A2 (hu) | Indolizinszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyászati készítmények | |
AR034259A1 (es) | Polimorfos de un analogo de epotilona, procesos para prepararlos y las composiciones farmaceuticas que los contienen | |
WO2003064404A1 (fr) | Hydrazides d'acide 2-furancarboxylique et compositions pharmaceutiques les contenant | |
NO20045103L (no) | Benzofuserte heteroarylamid-derivater av thienopyridiner anvendelige som terapeutiske midler, farmasoytiske blandinger omfattende de samme og fremgangsmater for deres anvendelse | |
CA2394120A1 (en) | Tricyclic fused heterocyclic compound, process for preparing it and medicament comprising it | |
WO2003097656A3 (en) | Novel substituted sulfamate anticonvulsant derivatives | |
AU663200B2 (en) | New 3-(hydroxybenzylidenyl)-indolin-2-ones, processes for their preparation and pharmaceutical compositions containing them | |
NO20052683L (no) | Nye pyridopyrimidinonforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
HUP0400682A2 (hu) | 5-Hidroxitriptamin-6-ligandumként használható heterociklilalkilindol- és -azaindol-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
BR9408325A (pt) | Composto composição farmacêutica e processo para a manufatura de um composto | |
HUT69391A (en) | Pregnanes and androstanes substituted by 2-beta-morpholine derivatives and pharmaceutical compositions containing the same and process for their production | |
EP1634874A4 (de) | Imidazolidinderivate | |
HUP0300370A2 (hu) | Antimikrobiális hatású 2-hidroxi-mutilin-karbamát-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
NO20016389L (no) | Fremgangsmåte for fremstilling av substituerte cyklopentanderivater og nye krystallinske strukturer derav | |
HUP0401883A2 (hu) | Muszkarin agonisták és ezeket tartalmazó gyógyászati készítmények | |
DE60002755D1 (de) | Benzothiadiazinderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen | |
HUP0204014A2 (hu) | N-helyettesített ciklikus vagy aciklikus aminok kvaterner sói gyógyszerkészítményekkénti alkalmazása | |
ATE395325T1 (de) | Neues kristallines stilben-derivat und verfahren zu dessen herstellung | |
CA2060616A1 (en) | Use of 4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine derivatives as free radical scavengers | |
WO2004091627A3 (en) | Heterocyclic substituted 1,4-dihydro-4-oxo-1,8-naphthpyridine analogs | |
EP1390343A4 (de) | Neue retinoidderivate und verfahren zur herstellung dieser verbindungen, sowie eine pharmazeutische anti-krebs-zusammensetzung, die diese verbindungen enthält | |
BR9707004A (pt) | Composto processo para preparar o mesmo composição farmacêutica utilização do composto e processos para tratamento de doenças do sistema endocinológico e para a manufatura de um medicamento | |
WO2000064902A3 (en) | Process for the preparation of calanolide precursors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1264821 Country of ref document: EP |